ZEPP Zepp Health Corp Annual reports only
Electronic Computers · NYSE · SEC CIK 1720446 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY41.8%
TTM net income YoY47.1%
TTM EPS YoY44.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin38.3%
Operating margin-11.3%
Net margin-15.5%
FCF margin-10.1%
EBITDA margin-9.5%
Returns
ROE-17.2%
ROA-7.3%
ROIC (approx.)-10.2%
Asset turnover0.47x
Leverage & solvency
Liabilities / assets62.0%
Debt / equity0.28x
Current ratio1.02x
Interest coverage-5.13x
Cash quality & payout
Operating cash flow / net income0.64x
Accruals ratio-2.6%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $258.90M | $182.60M |
| Cost of revenue | $159.71M | $112.37M |
| Gross profit | $99.19M | $70.23M |
| R&D expense | $45.32M | $46.16M |
| SG&A expense | $29.27M | $24.85M |
| Operating income | -$29.23M | -$47.25M |
| Interest expense | $5.70M | $5.55M |
| Pretax income | -$35.46M | -$57.90M |
| Income tax | $2.54M | $13.69M |
| Net income | -$40.07M | -$75.73M |
| EBITDA | -$24.70M | -$42.23M |
| EPS (basic) | -0.16 | -0.29 |
| EPS (diluted) | -0.16 | -0.29 |
| Weighted avg. shares (diluted) | 254.43M | 258.88M |
| Balance sheet | ||
| Cash & equivalents | $57.05M | $91.07M |
| Short-term investments | — | $997,000 |
| Receivables | $66.91M | $62.97M |
| Inventory | $72.76M | $56.79M |
| Current assets | $293.52M | $251.56M |
| PP&E, net | $5.66M | $6.90M |
| Goodwill | $9.58M | $9.58M |
| Intangibles | $13.61M | $7.09M |
| Total assets | $564.84M | $528.59M |
| Current liabilities | $286.84M | $195.37M |
| Long-term debt | $59.48M | $75.24M |
| Total debt | $59.48M | $75.24M |
| Total liabilities | $350.30M | $275.87M |
| Shareholders' equity | $214.53M | $251.59M |
| Net debt | $2.43M | -$15.83M |
| Cash flow statement | ||
| Operating cash flow | -$25.69M | -$24.39M |
| Capital expenditure | $516,000 | $1.40M |
| Free cash flow | -$26.21M | -$25.80M |
| Investing cash flow | $1.48M | -$1.58M |
| Financing cash flow | $24.84M | $477,000 |
| Depreciation & amortization | $4.54M | $5.02M |
| Stock-based compensation | $2.49M | $4.78M |
| Share buybacks | $1.24M | $2.28M |
Free plan shows the latest 2 periods; Pro shows all 11 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.